We are live on ! Find out more
WA

Whitebox Advisors Portfolio holdings

AUM $8.12B
1-Year Est. Return 15.85%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+15.85%
3 Year Est. Return
+25.69%
5 Year Est. Return
+33.73%
10 Year Est. Return
+176.02%
AUM
$7.05B
AUM Growth
+$584M
Cap. Flow
-$2.95B
Cap. Flow %
-41.91%
Top 10 Hldgs %
42.06%
Holding
552
New
124
Increased
32
Reduced
27
Closed
60

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$167M
2
COOP
Mr. Cooper
COOP
+$66.4M
3
WNS
WNS Holdings
WNS
+$59.5M
4
K
Kellanova
K
+$25.8M
5
INFA
Informatica
INFA
+$22.7M

Sector Composition

Rank Sector Weight
1 Financials 7.92%
2 Communication Services 2.48%
3 Industrials 2.43%
4 Healthcare 1.71%
5 Technology 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIIW
301
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$21.3M
$68.6K ﹤0.01%
125,000
GSHRW
302
Gesher Acquisition Corp II Warrants
GSHRW
$67.5K ﹤0.01%
150,000
BLUWW
303
Blue Water Acquisition Corp III Warrant
BLUWW
$66.3K ﹤0.01%
125,000
SVCCW
304
Stellar V Capital Corp Warrant
SVCCW
$66K ﹤0.01%
200,000
NOEMW
305
CO2 Energy Transition Corp Warrant
NOEMW
$65.7K ﹤0.01%
390,000
MBAVW
306
DELISTED
M3-Brigade Acquisition V Corp Warrant
MBAVW
$65.6K ﹤0.01%
75,000
LPAAW
307
Launch One Acquisition Corp Warrant
LPAAW
$63.9K ﹤0.01%
255,571
DMIIR
308
Drugs Made In America Acquisition II Corp Right
DMIIR
$63K ﹤0.01%
+450,000
New +$64.3K
EMISR
309
Emmis Acquisition Corp Rights
EMISR
$60.6K ﹤0.01%
+400,000
New +$63.6K
SPEGR
310
Silver Pegasus Acquisition Corp Rights
SPEGR
$60K ﹤0.01%
250,000
PAII.WS
311
Pyrophyte Acquisition Corp II Warrants
PAII.WS
$60K ﹤0.01%
150,000
TLNCW
312
Talon Capital Corp Warrants
TLNCW
$6.56M
$59K ﹤0.01%
+100,000
New +$71.3K
BACCR
313
Blue Acquisition Corp Right
BACCR
$56.7K ﹤0.01%
175,000
GRAF.WS
314
Graf Global Corp Warrants
GRAF.WS
$10.9M
$56.5K ﹤0.01%
125,000
NHICW
315
NewHold Investment Corp III Warrants
NHICW
$20.4M
$56.3K ﹤0.01%
125,000
OTGAW
316
OTG Acquisition Corp I Warrants
OTGAW
$56K ﹤0.01%
+175,000
New +$58.3K
HVIIR
317
Hennessy Capital Investment Corp VII Rights
HVIIR
$55.8K ﹤0.01%
200,000
LPBBW
318
Launch Two Acquisition Corp Warrant
LPBBW
$55.2K ﹤0.01%
175,000
YCY.WS
319
AA Mission Acquisition Corp II Warrants
YCY.WS
$55K ﹤0.01%
+250,000
New +$52.5K
LCCCR
320
Lakeshore Acquisition III Corp Rights
LCCCR
$54.9K ﹤0.01%
218,500
SIMAW
321
SIM Acquisition Corp I Warrant
SIMAW
$53.9K ﹤0.01%
250,000
BRRWW
322
ProCap Financial Inc
BRRWW
$52.5K ﹤0.01%
75,000
COLAR
323
Columbus Acquisition Corp Rights
COLAR
$50.5K ﹤0.01%
150,000
OYSER
324
Oyster Enterprises II Acquisition Corp Rights
OYSER
$50K ﹤0.01%
250,000
APADR
325
DELISTED
A Paradise Acquisition Corp Rights
APADR
$50K ﹤0.01%
+200,000
New +$45.9K

Similar funds

Whitebox Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Whitebox Advisors held 552 positions worth $7.05B, up 9% from $6.46B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Whitebox Advisors withdrew a net $2.95B in Q4 2025, closing 60 positions and reducing 27 holdings. Its most notable exit was Verona Pharma, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.9% of assets, up from 4.9% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Whitebox Advisors opened a new position in Cadence Bank worth $129M.

  • Whitebox Advisors's largest Q4 2025 buy was Cadence Bank: 3,000,001 shares worth $129M.
  • Whitebox Advisors added most to Chart Industries in Q4 2025, an estimated $49.1M increase.
  • Whitebox Advisors's biggest Q4 2025 reduction was Gulfport Energy Corp, cutting an estimated $9.97M.
  • Whitebox Advisors fully exited Verona Pharma in Q4 2025, selling an estimated $167M.
  • Whitebox Advisors's ten largest holdings make up 42% of its $7.05B portfolio in Q4 2025.
  • Whitebox Advisors opened 124 new positions and closed 60 in Q4 2025.
  • Whitebox Advisors's portfolio value rose 9% quarter-over-quarter to $7.05B.

Based on Whitebox Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.